Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone
Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone
MALVERN,...
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
Warner Chilcott Statement Regarding Market Speculation
Warner Chilcott Statement Regarding Market Speculation DUBLIN, Ireland, May 10, 2013 (GLOBE NEWSWIRE) -- Further to media speculation, the Board of Warner Chilcott plc (Nasdaq:WCRX) confirmed today...
Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc
Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc PARSIPPANY, N.J., May 10, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a global specialty...
DURECT Announces Update on Remoxy®
CUPERTINO, Calif., May 10, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Pfizer
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
LONDON and SOUTH SAN FRANCISCO, Calif., May 10, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK)
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
INDIANAPOLIS, May 10, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Phase III clinic
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. Class Action Asserts Company Discriminates Against Female Sales Reps NEWARK, N.J., May 9, 2013 -- Sanford...
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis Ilaris® (canakinumab) is the first interleukin-1 beta...
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients THOUSAND OAKS, Calif. and ZHEJIANG, China, May...
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients
THOUSAND OAKS, Calif. and ZHEJIANG,
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
ABBOTT PARK, Ill., May 9, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced CE Marking (Conformité Européenne) for the ARCHITE
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.
Class Action Asserts Company Discriminates Against Female Sales Reps
NEWARK, N.J., May 9, 2013 /PRNe
Dendreon Announces First Quarter 2013 Results
SEATTLE--(BUSINESS WIRE)--May 9, 2013--Dendreon Corporation (Nasdaq:DNDN) today reported results for the first quarter ended March 31, 2013. Net product revenue for the quarter was $67.6 million...
NPS Pharmaceuticals Reports First Quarter 2013 Financial Results
NPS Pharmaceuticals Reports First Quarter 2013 Financial Results -- Gattex launch off to a strong start with 160 prescriptions received to date and 42 patients now on therapy -- -- Strategic...
The European Alcohol Addiction Market is Poised For a Treatment Paradigm Shift With the Launch of BioTie/Lundbeck's Selincro
The European Alcohol Addiction Market is Poised For a Treatment Paradigm Shift With the Launch of BioTie/Lundbeck's Selincro In the Absence of Selincro, Acamprosate and Naltrexone Will Remain...
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck's HPV Vaccine, Available to Developing Countries through UNICEF Tender
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck's HPV Vaccine, Available to Developing Countries through UNICEF Tender
Thursday, May 9,...
GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world's poorest countries
GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world's poorest countries Issued: Thursday 9 May 2013, London UK GlaxoSmithKline (GSK) today...
Columbia Laboratories Reports First Quarter 2013 Financial Results
Columbia Laboratories Reports First Quarter 2013 Financial Results
IMS Health Study Points to a Declining Cost Curve for U.S. Medicines in 2012
Total Real Per Capita Spending on Medicines Fell 3.5 Percent; Fewer Doctor Office Visits and Non-Emergency Hospital Admissions; Prescription Use Down 0.1 Percent PARSIPPANY, NJ, May 9,...
